Incidence of cytomegalovirus infection after allogeneic stem cell transplantation conditioned with myeloablative and non-myeloablative regimens

被引：0
|
作者：
Irrera, I
Morabito, F
Cuzzola, M
Cuzzocrea, A
Iacopino, O
Penna, G
Console, G
Messina, G
Martino, M
Iacopino, P
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] Different immune reconstitution in patients with lymphoproliferative diseases after non-myeloablative and myeloablative allogeneic stem cell transplantation
    Dattola, A
    Condemi, A
    Cuzzola, M
    Iacopino, O
    Pontari, A
    Callea, I
    Martino, M
    Pucci, G
    Messina, G
    Irrera, G
    Console, G
    Marcuccio, D
    Morabito, F
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S358 - S358
  • [22] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
    Schrier, RW
    Parikh, CR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
  • [23] Autologous haematopoietic stem cell transplantation in multiple sclerosis: myeloablative versus non-myeloablative conditioning regimens
    Motuzova, Y.
    Fedulov, A.
    Uss, A.
    Milanovich, N.
    Zmachinsky, V.
    Baida, A.
    Minzer, M.
    Chernysh, E.
    Bulaev, I.
    Smolnikova, V.
    Drazhina, L.
    Solovieva, N.
    JOURNAL OF NEUROLOGY, 2010, 257 : S150 - S150
  • [24] Allogeneic non-myeloablative stem cell transplantation for refractory rheumatoid arthritis
    Burt, R
    Oyama, Y
    Barr, W
    Traynor, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S145 - S146
  • [25] Kinetics of engrafting donor cells after non-myeloablative allogeneic stem cell transplantation
    Carella, AM
    Corsetti, MT
    Beltrami, G
    Greco, MM
    Scalzulli, PR
    Carella, AM
    BONE MARROW TRANSPLANTATION, 2003, 31 : S149 - S149
  • [26] Infectious morbidity after non-myeloablative allogeneic hemapoietic stem cell transplantation (AHSCT)
    Thiébaut, A
    Antal, D
    Bilger, K
    Michallet, A
    Audigier, C
    Nicolini, F
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S148 - S148
  • [27] GVHD and CMV antigenemia after allogeneic peripheral blood stem cell transplantation: Comparison between myeloablative and non-myeloablative (MINI) conditioning regimens.
    Reddy, V
    Pollock, BH
    Sharda, S
    Hopkins, J
    Weeks, F
    Manion, K
    Roque, D
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Mehta, P
    Moreb, JS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 191A - 191A
  • [28] Early and late gastrointestinal complications after allogeneic stem cell transplantation following myeloablative and non-myeloablative conditioning.
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    BLOOD, 2002, 100 (11) : 631A - 631A
  • [29] Infections after allogeneic haematopoietic stem cell transplantation with a non-myeloablative conditioning regimen
    Frere, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2005, 35 : S164 - S164
  • [30] A comparative study of non-myeloablative and myeloablative allogeneic haematopoietic stem cell transplantation in the chronic myeloid leukaemia
    Ahmed-Nacer, R
    Benakli, M
    Hamladji, RM
    Talbi, AA
    Mehdid, F
    Belhadj, R
    Pierre, KB
    Curie, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S233 - S233
12345